Collectively, all of these observations suggest that MAD2L1 and BUB1, two genes present in multiple gene expression signatures for breast cancer prognosis, may be important molecules influencing tumor cell activity and patient survival. This evidence concerns the gene MAD2L1 and breast carcinoma.